Top Markets
Coin of the day
Anbio Biotechnology Class A Ordinary Shares Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology Class A Ordinary Shares

NNNN
Rank in Stocks #16102
Anbio Biotechnology, established in 2021 and based in Frankfurt am Main,... Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. The company's international footprint covers regions such as the European Union, Asia Pacific, North America, South America, and Africa. Their product range features various diagnostic solutions, including rapid antigen tests for SARS-CoV-2 (both individual and combined with influenza A/B). Anbio also develops and manufactures products leveraging advanced technologies like lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification (LAMP), chemiluminescence immunoassay (CLIA), and reverse-transcription polymerase chain reaction (RT-PCR). These offerings cater to a wide array of markets, including over-the-counter sales, point-of-care testing, and traditional laboratory settings.
Share Price
$7.15
Market Cap
$313.60M
Change (1 day)
-2.12%
Change (1 year)
-84.14%
Country
DE
Trade Anbio Biotechnology Class A Ordinary Shares (NNNN)

Category

Stock price history for Anbio Biotechnology Class A Ordinary Shares (NNNN)
Highest end of day price: $7.15 on 2026-09-01

Lowest end of day price: $6.12 on 2025-02-01
Stock price history of Anbio Biotechnology Class A Ordinary Shares from 2025 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -23.17%
2025 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$368.46 -22.15%
US
$188.84 -37.67%
FR
$162.52 24.14%
JP
$187.34 23.49%
US
$75.35 -5.80%
CH